Alfresa Partners with Kei Pharma on iPS Cell Therapy Supply Chain Development Alfresa Corporation has entered a basic agreement with Kei Pharma to collaborate on the iPS cell-derived regenerative medical product supply chain, enhancing healthcare delivery.

Alfresa Partners with Kei Pharma on iPS Cell Therapy Supply Chain Development #Tokyo #iPS_Cells #Alfresa #Kei_Pharma